PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24210682-0 2014 The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. phytocannabinoid 39-55 cannabinoid receptor 2 (macrophage) Mus musculus 16-19 31892132-5 2019 Therefore, we investigated the effect of beta-caryophyllene (BCP), a CB2-selective phytocannabinoid, in a model of NRTI-induced neuropathic pain. phytocannabinoid 83-99 cannabinoid receptor 2 (macrophage) Mus musculus 69-72 28368293-0 2017 (-)-beta-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis. phytocannabinoid 49-65 cannabinoid receptor 2 (macrophage) Mus musculus 26-29 28368293-1 2017 (-)-beta-caryophyllene (BCP), a cannabinoid receptor type 2 (CB2)-selective phytocannabinoid, has already been shown in precedent literature to exhibit both anti-inflammatory and analgesic effects in mouse models of inflammatory and neuropathic pain. phytocannabinoid 76-92 cannabinoid receptor 2 (macrophage) Mus musculus 61-64